Chiron Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.3M | Sell |
|
|||||
|
2025
Q1 | $18.3M | Sell |
|
|||||
|
2024
Q4 | $23.2M | Sell |
|
|||||
|
2024
Q3 | $23M | Sell |
|
|||||
|
2024
Q2 | $18.8M | Buy |
|
|||||
|
2024
Q1 | $24.2M | Buy |
|
|||||
|
2023
Q4 | $22.8M | Sell |
|
|||||
|
2023
Q3 | $27.3M | Sell |
|
|||||
|
2023
Q2 | $30.6M | Buy |
|
|||||
|
2023
Q1 | $33.1M | Sell |
|
|||||
|
2022
Q4 | $35M | Sell |
|
|||||
|
2022
Q3 | $37.1M | Sell |
|
|||||
|
2022
Q2 | $41.4M | Sell |
|
|||||
|
2022
Q1 | $45.1M | Sell |
|
|||||
|
2021
Q4 | $44.5M | Sell |
|
|||||
|
2021
Q3 | $42.3M | Buy |
|
|||||
|
2021
Q2 | $44.4M | Sell |
|
|||||
|
2021
Q1 | $48.3M | Sell |
|
|||||
|
2020
Q4 | $47.9M | Sell |
|
|||||
|
2020
Q3 | $47.3M | Buy |
|